These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31206232)

  • 1. Reduced expression of apolipoprotein E and immunoglobulin heavy constant gamma 1 proteins in Fuchs endothelial corneal dystrophy.
    Kuot A; Ronci M; Mills R; Klebe S; Snibson G; Wiffen S; Loh R; Corbett M; Zhou T; Chataway T; Burdon KP; Craig JE; Urbani A; Sharma S
    Clin Exp Ophthalmol; 2019 Nov; 47(8):1028-1042. PubMed ID: 31206232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential gene expression analysis of corneal endothelium indicates involvement of phagocytic activity in Fuchs' endothelial corneal dystrophy.
    Kuot A; Corbett MA; Mills RA; Snibson G; Wiffen S; Loh R; Burdon KP; Craig JE; Sharma S
    Exp Eye Res; 2021 Sep; 210():108692. PubMed ID: 34228965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of Fuchs' endothelial corneal dystrophy support that the extracellular matrix of Descemet's membrane is disordered.
    Poulsen ET; Dyrlund TF; Runager K; Scavenius C; Krogager TP; Højrup P; Thøgersen IB; Sanggaard KW; Vorum H; Hjortdal J; Enghild JJ
    J Proteome Res; 2014 Nov; 13(11):4659-67. PubMed ID: 24846694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
    Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
    Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shotgun proteomics identification of proteins expressed in the Descemet's membrane of patients with Fuchs endothelial corneal dystrophy.
    Nakagawa T; Okumura N; Ikegawa M; Toyama Y; Nirasawa T; Mascarelli F; Vaitinadapoule H; Aouimeur I; He Z; Gain P; Thuret G; Koizumi N
    Sci Rep; 2023 Jun; 13(1):10401. PubMed ID: 37369713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end products and receptors in Fuchs' dystrophy corneas undergoing Descemet's stripping with endothelial keratoplasty.
    Wang Z; Handa JT; Green WR; Stark WJ; Weinberg RS; Jun AS
    Ophthalmology; 2007 Aug; 114(8):1453-60. PubMed ID: 17320180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colocalization of increased transforming growth factor-beta-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy.
    Jurkunas UV; Bitar M; Rawe I
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1129-36. PubMed ID: 19011008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model.
    Okumura N; Matsumoto D; Fukui Y; Teramoto M; Imai H; Kurosawa T; Shimada T; Kruse F; Schlötzer-Schrehardt U; Kinoshita S; Koizumi N
    PLoS One; 2018; 13(1):e0191306. PubMed ID: 29338061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix alterations in late-onset Fuchs' corneal dystrophy.
    Weller JM; Zenkel M; Schlötzer-Schrehardt U; Bachmann BO; Tourtas T; Kruse FE
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3700-8. PubMed ID: 24833739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trinucleotide Repeat Expansion in the Transcription Factor 4 (TCF4) Gene Leads to Widespread mRNA Splicing Changes in Fuchs' Endothelial Corneal Dystrophy.
    Wieben ED; Aleff RA; Tang X; Butz ML; Kalari KR; Highsmith EW; Jen J; Vasmatzis G; Patel SV; Maguire LJ; Baratz KH; Fautsch MP
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):343-352. PubMed ID: 28118661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Impact of Fibronectin, Tenascin-C, Osteopontin, and Type XIV Collagen in Fuchs Endothelial Corneal Dystrophy.
    Tchatchouang A; Brunette I; Rochette PJ; Proulx S
    Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):38. PubMed ID: 38656280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Trinucleotide Repeat Expansion on the Expression of TCF4 mRNA in Fuchs' Endothelial Corneal Dystrophy.
    Okumura N; Hayashi R; Nakano M; Yoshii K; Tashiro K; Sato T; Blake DJ; Aleff R; Butz M; Highsmith EW; Wieben ED; Fautsch MP; Baratz KH; Komori Y; Nakahara M; Tourtas T; Schlötzer-Schrehardt U; Kruse F; Koizumi N
    Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):779-786. PubMed ID: 30811544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Cdkn1a (p21) overexpression and accelerated senescence in a mouse model of Fuchs endothelial corneal dystrophy.
    Matthaei M; Meng H; Meeker AK; Eberhart CG; Jun AS
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6718-27. PubMed ID: 22956607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of Fuchs' endothelial dystrophy--a review of molecular and cellular insights.
    Zhang J; Patel DV
    Exp Eye Res; 2015 Jan; 130():97-105. PubMed ID: 25446318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Matrix and Integrin Expression Profiles in Fuchs Endothelial Corneal Dystrophy Cells and Tissue Model.
    Goyer B; Thériault M; Gendron SP; Brunette I; Rochette PJ; Proulx S
    Tissue Eng Part A; 2018 Apr; 24(7-8):607-615. PubMed ID: 28726551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased clusterin expression in Fuchs' endothelial dystrophy.
    Jurkunas UV; Bitar MS; Rawe I; Harris DL; Colby K; Joyce NC
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2946-55. PubMed ID: 18378577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomechanical changes to Descemet's membrane precede endothelial cell loss in an early-onset murine model of Fuchs endothelial corneal dystrophy.
    Leonard BC; Jalilian I; Raghunathan VK; Wang W; Jun AS; Murphy CJ; Thomasy SM
    Exp Eye Res; 2019 Mar; 180():18-22. PubMed ID: 30471280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell microRNA expression in human late-onset Fuchs' dystrophy.
    Matthaei M; Hu J; Kallay L; Eberhart CG; Cursiefen C; Qian J; Lackner EM; Jun AS
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):216-25. PubMed ID: 24334445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy.
    Jurkunas UV; Rawe I; Bitar MS; Zhu C; Harris DL; Colby K; Joyce NC
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2956-63. PubMed ID: 18378575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ion transporters and increased unfolded protein response in Fuchs' dystrophy.
    Jalimarada SS; Ogando DG; Bonanno JA
    Mol Vis; 2014; 20():1668-79. PubMed ID: 25548511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.